Syndax Pharmaceuticals, Inc. (SNDX)
19.41
-0.82
(-4.05%)
USD |
NASDAQ |
May 18, 16:00
19.41
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals EPS Diluted (Quarterly) : -0.4835 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.60 |
| Vera Therapeutics, Inc. | -1.693 |
| Biogen, Inc. | 2.153 |
| Amgen, Inc. | 3.344 |
| Ardelyx, Inc. | -0.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.67M |
| Revenue (Quarterly) | 64.86M |
| Total Expenses (Quarterly) | 107.54M |
| Enterprise Value | 1.786B |
| Gross Profit Margin (Quarterly) | 95.93% |
| Profit Margin (Quarterly) | -65.79% |
| Earnings Yield | -14.40% |
| Normalized Earnings Yield | -14.40 |